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Introduction
Regular physical exercise is recommended for the primary 
prevention of cardiovascular (CV) disease (1). In recent 
years, participation in competitions such as marathon, 
semi-marathon and cycling events has become increasingly 
popular. There is a small number of high-performance 
professional athletes between 18 and 35 years physically 
well monitored and medically supervised, however the 
number of non-professional athletes with individuals of all 
age groups is increasing. Physical exercise has a clear overall 
benefit, but there is a small but significant increase in the 
risk of sudden cardiac death during or shortly after vigorous 
exercise (2) especially in older athletes (3). 
Data on the long-term effect of vigorous exercise on 
CV risk in presumably healthy individuals participating in 
marathons or half marathons are limited. It is important 
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to look at the benefit of exercise training, but also try 
to evaluate possible negative effect of extreme physical 
exercise.
There are several studies on cardiac biomarker 
changes .  Mi ld  to  modera te  e l eva t ions  in  those 
markers have been described as a result of a running 
exercise (4,5). Exact underlying mechanism for these 
biomarker elevations reflecting physiological or even 
pathophysiological changes is unknown and less trained 
athletes might exhibit a higher cardiac risk compared to 
well-trained runners. 
High-sensitivity cardiac troponin (cTn) assays are 
now available that can reliably measure cTn levels in low 
concentrations seen in healthy individuals (6). Detectable 
cTn levels determined with high sensitivity troponin 
assays in athletes have been reported from different 
studies (7,8). Additional marker for potential cardiac 
stretch and potential myocardial fibrotic processes during 
endurance training are natriuretic peptides (NPs) and 
Galectin-3 (Gal-3) (9).
The aim of this study was to evaluate cardiac biomarker 
levels in well trained athletes, healthy runners, completing 
a marathon or semi marathon compared to a control group 
consisting of healthy, untrained individuals completing 
1 hour of running and to highlight the impact on the lab 
results interpretation in emergency department. 
Methods
Subjects
Included in the study were healthy male marathon (n=23), 
semi-marathon runners (n=15) and a control group of 
untrained runners (n=17). The exclusion criterion was “no 
history of cardiovascular disease”. The marathon runners 
were well trained athletes with a weekly training plan of 
5 h 28 min ±2 h 33 min, semi-marathon runners weekly 
training plan was 4 h 22 min ±1 h 29 min. Weekly exercise 
in the control group of untrained runners was below 2 h. 
Training levels and training duration of the control group 
corresponds to the general recommendation for weekly 
exercise.
Running exercise duration was different for the different 
runner groups. Median duration to complete the marathon 
run was 3 h 50 min 48 sec (±27 min 30 sec) and 1 h 55 min 
18 sec (±15 min 31 sec) for the semi-marathon. Control 
group was asked to run for 1 hour in an athletic stadium 
being at their limit at the end of the exercise.
Samples
For all participants, a blood sample was taken before the 
beginning of the exercise (pre-exercise T0), directly (T 
post) and 3 hours (T 3 h post) after end of the exercise.
Blood samples (EDTA-, Lithium Heparin-plasma 
and serum) were centrifuged immediately after the draw 
for 10 minutes at 2,500 g, aliquoted and stored frozen at 
−80 ℃ before further analysis. The heart rate and the blood 
pressure were monitored at the same time of the blood 
draw.
Study was approved by Ethic committee of the University 
of Liege. All the subjects signed an informed consent.
Biomarkers determination
Hematocrit and hemoglobin levels were determined at all 3 
time points to correct for possible post exercise dehydration.
All the biomarkers, cardiac biomarkers: high sensitivity 
(hs) cTnI and hs cTnT, B-type natriuretic peptide (BNP) 
and N-terminal Pro BNP (NT-ProBNP), creatin kinase 
(CK), creatin kinase-isoenzym MB (CKMB), myoglobin 
(MYO) and Gal-3, inflammation and renal biomarkers: 
C-reactive protein (CRP), myeloperoxydase (MPO), 
creatinine (Crea) and cystatin C (CysC), were measured in 
the stored aliquots.
Hs cTnI, BNP and Gal-3 were measured on the 
Abbott ARCHITECT i2000SR immunoanalyzers (Abbott 
Laboratories, Germany), hs cTnT and NT-ProBNP on 
the Roche Elecsys system (Roche Diagnostics, Switzerland) 
according to the manufacturer’s instructions for use. CK, 
CK MB, MYO, CRP and Crea were measured on the 
Roche Elecsys system (Roche Diagnostics, Switzerland). 
MPO was measured with a kit from Immundiagnostik 
(Bensheim, Germany) on an Etimax (Diasorin, Italy) 
and CysC was measured on a Vista (Siemens, Germany) 
according to the manufacturer’s instructions for use. 
The analytical performances of the studied biomarkers 
are summarized in the Table 1 (6,10-16). 
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
8.0.0 and Analyse-it for Microsoft Excel (version 2.30) and 
JMP version 12.0. Categorical data were summarized with 
number and percentages. Results are generally expressed as 
median with 25th–75th percentiles. Comparison between 
the groups was performed using a Kruskal-Wallis test with 
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Bonferroni correction. Pearson Correlation was done to 
determine the degree of association between 2 variables.
Results
Median age, height, weight, body mass index (BMI), 
heart rate and systolic blood pressure of the 3 study 
groups are summarized in Table 2. There were no medical 
problems reported before or after the exercise in any of the 
participating well-trained athletes and the control group. All 
runners completed the runs without any reported problems 
during or after the exercise.
Pre-exercise levels
Cardiac biomarker levels between marathon runners 
and semi-marathon runners did not show a statistically 
significant difference in the pre-exercise samples for 
Troponin I and T, BNP, NT-ProBNP and Gal-3 (Table 3). 
All untrained runners had pre-exercise cTn I and T 
levels below the 99th percentile except for one marathon 
and two semi-marathon runners with cTn levels above 99th 
percentile before start of the run. Elevated BNP (>35 ng/L) 
value was seen in one marathon and one semi-marathon 
runner before start of the run. NT-ProBNP levels in the 
pre-exercise samples of all three running groups were all 
below 125 ng/L, Gal-3 levels were below 95th percentile 
derived from healthy individuals.
Dehydration during the run
There was an average 5% increase in hemoglobin 
concentration between the pre-exercise sample and the 
sample drawn immediately after the exercise for well-trained 
athletes. Hemoglobin levels in the sample drawn 3 hours 
post-exercise were comparable to pre-run levels indicating 
increase in values due to dehydration effect directly after 
the run. This was not seen in the control group after 1-hour 
running. When corrected for hemoglobin concentration 
cardiac biomarker levels were not significantly different.
Heart rate and arterial blood pressure
Heart rate and arterial pressure of the trained athletes and 
the control group were measured at all 3 time points, before, 
directly after and 3 hours after the running exercise (Table 2). 
Significant lowest heart rate before the run was seen for the 
marathon runners, control group had the highest heart rate. 
Directly after the run there was a significant increase in heart 
rate for all groups which decreased 3 hours later, however 
heart rate was still higher when compared to initial value. 
Arterial pressure decreased in all groups after the running 
Table 1 Summary of the analytical performances of the different studied biomarkers (6,10-18)
Parameters LOD LOQ or CV of 10% 99th percentile Recommended threshold
TnI 1.9 ng/L 5 ng/L 26.2 ng/L –
TnT 5 ng/L 13 ng/L 14 ng/L –
BNP 10 ng/L – – 35 ng/L
NT-pro 5 ng/L 30 ng/L – 125 ng/L
Gal-3 – 6 ng/L 25.7 ng/mL (95th) –
CK 7 UI/L 1 UI/L 20 UI/L (95th) 30–175 UI/L
CKMB 0.1 µg/L 1 µg/L 6.22 µg/L 0–6 µg/L
MYO 21 µg/L 1 µg/L 72 µg/L (97.5th) 28–72 µg/L
CRP 0.3 µg/L 0.6 µg/L – 0–6 mg/L
Crea 0.06 mg/L 0.195 mg/L 1.18 mg/L (97.5th) 0.73–1.18 mg/L
Cys C 0.27 mg/L 0.66 mg/L – 0.62–1.11 mg/L
MPO 1.6 ng/mL – 55 ng/mL (90th) –
LOD, limit of detection; LOQ, limit of quantitation; CV, cardiovascular; BNP, B-type natriuretic peptide; Gal-3, galectin-3; CK, creatin 
kinase; CKMB, creatin kinase-isoenzym MB; MYO, myoglobin; CRP, C-reactive protein; Crea, creatinine; Cys C, cystatin C; MPO, 
myeloperoxydase.
Journal of Laboratory and Precision Medicine, 2019Page 4 of 10
© Journal of Laboratory and Precision Medicine. All rights reserved. J Lab Precis Med 2019;4:6jlpm.amegroups.com
exercise and also stayed low 3 hours after the exercise.
Change of biomarker levels during and after the run
For all marker’s levels and the change of levels during and 
after the run are the highest in the marathon runner group. 
The lowest levels, but also the lowest effect of exercise on 
biomarker level increase is seen in the control group.
Median Troponin I, Troponin T, BNP, NT-ProBNP and 
Gal-3 levels plus interquartile range (IQR) in the 3 running 
groups before exercise, directly after completion of the run 
and 3 hours after completion are summarized in Table 3. The 
percentage changes of biomarker level between pre-, post 
and 3-hour post exercise level is summarized in Figure 1.
Average duration of the running exercise was 3 hours 
51 minutes for the marathon, 1 hour 55 minutes for the 
semi-marathon and 1 hour for the untrained runners. The 
hourly increase of biomarker levels during the running 
exercise expressed as percentage of the pre-exercise baseline 
level is highest for cTn I (325%, 220%, 20% for marathon, 
semi-marathon and untrained runners), for cTn T (149%, 
196% and 18%), for BNP (2%, 28% and 20%), for NT-
ProBNP (78%, 179% and 51%) and for Gal-3 (39%, 47% 
and 29%). After completion of the running exercise NP 
values stabilized or decreased, however, for cTn I and T 
levels continued to increase. 
Troponin I and T levels were significantly correlated to CK 
and CKMB. Troponin T values were additionally correlated to 
Gal-3, NT-ProBNP, BNP, CysC, Crea and MYO. 
BNP and NT-Pro-BNP correlat ion was highly 
significant. NT-ProBNP however also showed significant 
correlation to most other markers (Gal-3, TnT, CK, CKMB 
Table 2 Median age, height, weight BMI, heart rate and arterial blood pressure of the 3 different study groups, well trained-athletes completing 
marathon and semi marathon and control group of untrained healthy runners
Characteristics Marathon (n=23) Semi-Marathon (n=15) Control (n=17) P value
Age (years) 41 [37–50] 36 [30–44] 37 [35–41] 0.1510
Gender (M/F) M M M ns
Height (cm) 176 [170–183] 179 [175–184] 177 [172–184] 0.3631
Weight (kg) 74 [65–80] 74 [67–81] 78 [67–93] 0.6450
BMI (kg/m2) 23 [22–26] 23 [21–24] 24 [22–26] 0.5069
Heart rate (per min)
T0 56 [49–65] 63 [55–74] 65 [63–81] 0.0204#
T post 98 [92–116] 125 [102–178] 100 [90–108] 0.0886
T 3h post 79 [70–87] 81[76–85] 82 [71–91] 0.4660
P value 0.0022# <0.0001* <0.0001*
Arterial pressure (PAS) (mmHg)
T0 120 [120–130] 120 [110–123] 124 [120–135] 0.0952
T post 95 [90–103] 110[102–113] 116 [113–121] <0.0001*
T 3 h post 106 [98–113] 108[105–111] 120 [110–130] 0.0034#
P value <0.0001* 0.0135# 0.1435
Arterial pressure (PAD) (mmHg)
T0 80 [60–80] 70 [70–80] 85 [75–93] 0.0049#
T post 56 [52–66] 68[61–70] 81 [77–88] <0.0001*
T 3 h post 69 [62–72] 65[62–71] 79 [72–81] 0.0029#
P value 0.2223 0.0229# 0.1862
*, P<0.001; #, P<0.05. IQR, inter quartile range; BMI, body mass index; PAS, pulmonary arterial systolic; PAD, pulmonary arterial diastolic.
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CRP, CysC, Crea and MYO).
Gal-3 levels were highly correlated to TnT, NT-
ProBNP, CK, CKMB, CRP, CysC, Crea and MYO (Table 4).
Discussion
The aim of our study was to compare cardiac biomarker 
kinetics in runners at different time points depending 
on the exercise duration and training status of healthy 
athletes. Participants in the marathon and semi-marathon 
run were well trained with similar training levels and 
duration, ‘control’ group runners were selected based on a 
training levels of less than 2 hours per week, which was just 
below the general recommendation for health-enhancing 
physical activity, an interesting group of middle age healthy 
individuals’ representative of a more sedentary life style 
with higher risk of CV disease due to low sport activity.
Three cardiac biomarkers targeting different cardiac 
abnormal pathways were tested in the three running groups 
with different running time and training level. Cardiac T 
and I troponins (cTnT and cTnI) are currently regarded 
as reference markers of myocardial necrosis based on their 
Table 3 Median biomarker levels plus IQR before, directly after and 3 hours after end of exercise in the different groups
Athletes T0 T post T 3 h post P value
Median hs-TnI (ng/mL, IQR)
Marathon (n=19) 4.9 (2.9–7.6) 40.2 (20.5–81.4) 58.1 (30.1–74.3) <0.001*
Semi–Marathon (n=12) 3.5 (1.6–7.5) 17.1 (10.2–23.8) 56.4 (35.1–219.6) <0.001*
Control (n=16) 2.5 (1.9–3.9) 4.0 (2.3–5.7) 10.4 (4.8–17.0) 0.0012#
P value 0.1565 <0.0001* <0.0001*
Median hs-TnT (ng/mL, IQR)
Marathon (n=23) <5 30.0 (17.0–43.0) 28.0 (18.0–38.0) <0.0001*
Semi-Marathon (n=) 6.0 (5.0–7.0) 26.0 (16.0–39.0) 45.0 (18.0–68.0) <0.0001*
Control (n=14) <5 5.0 (5.0–6.0) 8.0 (5.0–19.0) 0.0027#
P value 0.0549 <0.0001* <0.0001*
Median BNP (ng/L, IQR)
Marathon (n=20) 10 [10–18] 13 [10–21] 13 [11–21] 0.1838
Semi-Marathon (n=15) 10 [10–14] 12 [10–18] 14 [10–20] 0.1044
Control (n=16) 11 [10–13] 13 [10–20] 10 [10–17] 0.2848
P value 0.5304 0.9295 0.0813
Median NT-proBNP (ng/L, IQR)
Marathon (n=23) 30 [20–37) 83 [61–109] 70 [51–120] <0.0001*
Semi-Marathon (n=15) 18 [8–21] 58 [47–85] 48 [43–83] <0.0001*
Control (n=17) 29 [19–36] 40 [32–48] 37 [27–49] 0.1239
P value 0.0982 0.0020# 0.0038#
Median Gal-3 (ng/L, IQR)
Marathon (n=20) 10 [9–12] 27 [22–29] 18 [16–21] <0.0001*
Semi-Marathon (n=14) 13 [10–16] 23 [22–26] 18 [15–21] <0.0001*
Control (n=17) 10 [9–13] 14 [12–16] 13 [11–15] 0.0048#
P value 0.0531 <0.0001* 0.0002*
*, P<0.001; #, P<0.05. IQR, inter quartile range.
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excellent sensitivity and cardio specificity (17). Brain NPs 
are hormones synthesized by cardiomyocytes (13). High 
blood concentrations reflect a high myocardial afterload 
tension due to the stretching of the myocytes, Gal-3 is a 
marker of cardiac fibrosis (18,19). 
Several studies looking at cardiac biomarker kinetics 
during different types of exercises like running, rowing or 
basketball playing have reported increase of biomarkers 
after stringent exercise (9,20)
In this study, we have seen that cTn increased in trained 
athletes, like marathon and semi-marathon runners during 
the run and continued to rise 3 hours after completion of 
running exercise. There is no consensus on pathophysiology 
and probable clinical impact of cTn elevation in athletes 
during and after the run. Different possible mechanisms have 
been proposed for Troponin release during the run including 
higher membrane permeability due to increased mechanical 
stress on the cardiomyocytes (bleb), increased production of 
oxidative radicals or altered acid base balance (20-24). The 
fact that the same Troponin release pattern during and post 
exercise is not only seen in trained athletes but also in the 
control group is of special interest. Heart rate increased and 
stayed high also 3 hours after completion of the run. Ischemic 
conditioning during and continuing after the race could cause 
100% 200% 300% 400% 500% 0%
M SM C
Galectin Increase T0 to 3h post
Galectin Increase T0 to T post
NT-ProBNP Increase T0 to 3h post
NT-ProBNP Increase T0 to T post
BNP Increase T0 to 3 h post
BNP  Increase T0 to T post
HS TnT Increase T0 to 3 h post
hs TnT Increase T0 to T post
Hs TnI increase  T0 to 3 h post
Hs TnI  Increase T0 to T post
600%
Hourly percent change of biomarker level
baseline to post excercise and baseline to 3 hour post excercise
Figure 1 Hourly percent change for well trained-athletes completing marathon and semi marathon and control group of untrained healthy 
runners between baseline, post and 3-hour post exercise biomarker level. For marathon runners, this is the hourly change for an average 
duration of 3 hours 51 minutes, for semi-marathon runners this is 1 h 55 minutes and for the control group this is 1 hour.
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transient, most likely reversible increased cardiomyocyte 
turn-over, as several studies could show that cTn increase 
during exercise was not associated with any immediate or 
longer-term functional impairment (25,26). 
In all three running groups baseline cTnI values were 
above the limit of detection (LOD), baseline cTnT values 
were at the LOD of the assay. This reflects the differences 
in analytical sensitivity of the 2 cTn assays, which had been 
previously described (6).
Long term training effect possibly causing heart muscle 
enlargement could be a possible explanation for the higher 
baseline cTnI values seen in the trained athletes when 
compared to control group. This effect was confirmed in 
another study looking at the consequences of endurance 
training on cTn values (27-29). 
cTn increases were seen in all running groups and levels 
were in some cases higher than the 99th percentile upper 
reference value of a normal population in 50% of the 
marathon and semi-marathon runners. Dynamics of cTn 
release are essential for diagnosing myocardial infarction 
in symptomatic chest pain patients and current guidelines 
indicate that clinical symptoms as well as a rise/fall of cTn 
are required for the diagnosis of AMI (17,30). This must be 
always checked when symptomatic patients after exercising 
are presenting to emergency room with possible diagnosis 
of myocardial infarction as this could possibly cause 
difficulties in diagnosis of acute myocardial infarction (31). 
Even relative low impact 1 hour running in untrained 
runners could result in cTn values above the 99th percentile 
upper reference limit. 
NPs play an important role in the regulation of cardiac 
function. Running exercise leads to a small but significant 
increase of both NPs; BNP and NT-ProBNP in all 3 
running groups. It has been described that exercise induced 
increase of NPs was associated with exercise duration, a 
fact which is confirmed with this study. The increase in the 
higher impact running group was more pronounced when 
compared to control running group. NP increase may be 
related transient myocardial wall stress, cardiomyocyte 
metabolic effects or exercise induced neuro endocrine 
response to the myocardial stretch (32).
Ischemia can trigger inflammatory response, along with 
macrophage infiltration and fibroblast activation (33). This 
could also be the explanation for the significant Gal-3 
increase in all 3 groups, being higher in the more stringent 
and longer distance runners. A similar drastic increase of 
Gal-3 correlating with the intensity and duration of exercise 
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impact on heart function was shown after further analysis 
by cardiac magnetic resonance testing (CMR) and 2D and 
3D echocardiography to assess left and right ventricular 
ejection fraction (34). 
Exercise induced right ventricular dysfunction and 
structural remodeling has been described in endurance 
athletes, however long-term consequences are still not 
defined (35). Recent results of a contrast-enhanced CV 
magnetic resonance study have questioned the development 
of an exercise induced right ventricular cardiomyopathy (26). 
In the absence of long-term follow-up studies this 
conclusion should be viewed with caution. 
Observed changes for cTn and Gal-3 levels were 
exceeding the short- and long-term biological variability 
reported (36). Variability of the individual cTn and Gal-
3 response at the different time points in the running 
groups was also high, with more extreme elevations in some 
runners. The inter-individual variability with a low index of 
individuality could be one reason for the different patterns in 
cTn responses (16,37). However, as described also in other 
studies, major factors influencing cTn and Gal-3 elevations 
are duration and intensity of the running exercise (36,37).
NT-ProBNP is the inactive part with longer half-
life, which is cleared only by the kidney. BNP is the 
active hormone with shorter half-life and break down 
via additional pathways through specific receptors and 
circulating endogenous peptidases. Direct influence of 
kidney impairment on NT-ProBNP could be the reason for 
the stronger association with renal dysfunction observed in 
patients with heart failure but also in the different running 
groups after stringent exercise (38).
Gal-3 levels in the different running groups also showed 
significant correlation to the renal function markers 
Creatinine and Cystatin C. Independent association of Gal-
3 levels with renal function has been described however it is 
suggested that it is also causally involved in mechanisms of 
tubulointerstitial fibrosis and CKD progression (39).
Major strength of our study was the compliance to the 
same protocol for the 3 running groups using same devices 
for blood drawing, same investigator and parallel testing of 
the cardiac markers, therefore no bias due to these points. 
There were several limitations to this study. The number 
of athletes in the different running group is quite low due to 
the difficulties to recruit such individuals especially for the 
blood test 3h after the run. Nevertheless, our data shows 
that all three cardiac biomarkers increase in the different 
running groups, with lower intensity in the control group. 
There was also no longer-term follow-up of patients, so 
the increases of the three cardiac biomarkers could not be 
related to longer term outcomes.
In conclusion, the question whether running exercise 
of different intensity could be harmful to the heart has no 
simple answer. We could show that running exercise can be 
associated with biochemical abnormalities that may reflect 
adverse consequences on the heart like possible micro 
necrosis, oxidative stress, fibrosis and myocardial stretch. 
With exception of Troponin where levels continue to raise 
after end of running, NPs and Gal-3 levels normalized 
relatively fast after the exercise proofing that stringent 
exercise induced heart stretch and induced inflammatory 
processes may be not sufficient to cause longer term heart 
remodeling and fibrosis. The possible harmful effect of 
longer-term cardiac consequences of repeated intensive 
sport activities still needs to be demonstrated. Short term 
however exercise induced changes in Troponin levels 
should be excluded in chest pain patients presenting to the 
emergency department.
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